Citation Impact
Citing Papers
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
2011 Standout
Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
2009 StandoutNobel
Transferrin receptor targeting by de novo sheet extension
2021 StandoutNobel
Designed protein logic to target cells with precise combinations of surface antigens
2020 StandoutScienceNobel
Bump-and-Hole Engineering Identifies Specific Substrates of Glycosyltransferases in Living Cells
2020 StandoutNobel
Diagnosis and Management of Pituitary Carcinomas
2005
Review on heterogeneous photocatalytic disinfection of waterborne, airborne, and foodborne viruses: Can we win against pathogenic viruses?
2020 Standout
Acromegaly
2006 Standout
CDK inhibitors: positive and negative regulators of G1-phase progression
1999 Standout
The p16INK4a/CDKN2A tumor suppressor and its relatives
1998
The RB and p53 pathways in cancer
2002 Standout
Cyclin D and cyclin E expression in normal and adenomatous pituitary
2000
DNA methylation patterns and epigenetic memory
2002 Standout
SOCS proteins, cytokine signalling and immune regulation
2007 Standout
Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis
2003
Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG
2006 Standout
DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death
2004
Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis
2006 Standout
Cushing's syndrome
2015 Standout
Autophagy as a cell death and tumor suppressor mechanism
2004 Standout
Molecular defects in the pathogenesis of pituitary tumours
2003
CDKN2A Mutation Analysis, Protein Expression, and Deletion Mapping of Chromosome 9p in Conventional Clear-Cell Renal Carcinomas
2001
Head and neck cancer
2008 Standout
The pathogenesis of pituitary tumours
2002
Cyclin D1: polymorphism, aberrant splicing and cancer risk
2006
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
2005 Standout
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
2019 StandoutNobel
Global expression profiling of murine MEN1‐associated tumors reveals a regulatory role for menin in transcription, cell cycle and chromatin remodelling
2007
Novel Patterns of Gene Expression in Pituitary Adenomas Identified by Complementary Deoxyribonucleic Acid Microarrays and Quantitative Reverse Transcription-Polymerase Chain Reaction1
2001
Modulation of Cell Cycle Components by Epigenetic and Genetic Events
2005
Characteristic promoter hypermethylation signatures in male germ cell tumors.
2002
Biological roles of glycans
2016 Standout
Methylation matters
2001
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Cancer genes and the pathways they control
2004 Standout
MEDICAL TREATMENT OF PROLACTINOMAS
1999
RB and cell cycle progression
2006 Standout
DAPk Protein Family and Cancer
2006
Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
2022 StandoutNobel
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
The prevalence of pituitary adenomas
2004 Standout
Testicular germ-cell tumours in a broader perspective
2005 Standout
Autophagy in the Pathogenesis of Disease
2008 Standout
Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression
2001 StandoutNobel
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Natural and synthetic polymers for wounds and burns dressing
2013
p16(MTS-1/CDKN2/INK4a) in Cancer Progression
2001
Corticotroph carcinoma of the pituitary: a clinicopathological study
2002
The VHL/HIF axis in clear cell renal carcinoma
2012 StandoutNobel
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Genetics and Proteomics of Pituitary Tumors
2005
The 2004 World Health Organization classification of pituitary tumors: What is new?
2005
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
2005 Standout
Genomic instability — the engine of tumorigenesis?
2003
Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma
2003
The chronostratigraphy of the Haua Fteah cave (Cyrenaica, northeast Libya)
2013
Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
2008 Standout
Crosstalk in NF-κB signaling pathways
2011 Standout
Selective In Vivo and In Vitro Effects of a Small Molecule Inhibitor of Cyclin-Dependent Kinase 4
2001
Mechanisms for pituitary tumorigenesis: the plastic pituitary
2003
Autophagy in cell death: an innocent convict?
2005 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Cushing's syndrome
2006 Standout
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Quantitative Super-Resolution Microscopy of the Mammalian Glycocalyx
2019 StandoutNobel
The epidemiology and genetics of pituitary adenomas
2009
Inactivation credit of UV radiation for viruses, bacteria and protozoan (oo)cysts in water: A review
2005 Standout
Pathogenesis of pituitary tumors
2011
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers
1999
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
Approach to the Cushing's Disease Patient With Persistent/Recurrent Hypercortisolism After Pituitary Surgery
2013
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Selective Loss of MEG3 Expression and Intergenic Differentially Methylated Region Hypermethylation in the MEG3/DLK1 Locus in Human Clinically Nonfunctioning Pituitary Adenomas
2008
Apoptosis: A Review of Programmed Cell Death
2007 Standout
The role of cryptotephra in refining the chronology of Late Pleistocene human evolution and cultural change in North Africa
2014
The role of microRNA genes in papillary thyroid carcinoma
2005 Standout
Advances in the Treatment of Prolactinomas
2006
Pleistocene North African genomes link Near Eastern and sub-Saharan African human populations
2018 StandoutScienceNobel
Functional Hydrogels as Wound Dressing to Enhance Wound Healing
2021 Standout
The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle
2005
Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
2013
Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line
2004
Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic Cells
2005 Standout
The Molecular Pathogenesis of Corticotroph Tumors
1999
Cells Lacking IKKα Show Nuclear Cyclin D1 Overexpression and a Neoplastic Phenotype: Role of IKKα as a Tumor Suppressor
2011
Pituitary Carcinoma: A Clinicopathological Review
2005
Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors
2011
A novel regulatory element (E77) isolated from CHO‐K1 genomic DNA enhances stable gene expression in Chinese hamster ovary cells
2016
Dysregulation of the TSC-mTOR pathway in human disease
2004 Standout
Mechanisms for pituitary tumorigenesis: the plastic pituitary
2003
Autophagy in Health and Disease: A Double-Edged Sword
2004 StandoutScience
Works of David J. Simpson being referenced
Loss of expression of the growth inhibitory gene GADD45γ, in human pituitary adenomas, is associated with CpG island methylation
2003
CpG-island fragments from the HNRPA2B1/CBX3genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells
2005
Genome‐wide amplification and allelotyping of sporadic pituitary adenomas identify novel regions of genetic loss
2003
Preferential loss of Death Associated Protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion
2002
Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas
2001
Genomic sequence analysis of a key residue (Arg183) in human Gαq in invasive non‐functional pituitary adenomas
1997
Wound healing and the immune response in swine treated with a hemostatic bandage composed of salmon thrombin and fibrinogen
2009
Pituitary tumours are multiclonal from the outset: evidence from a case with dural metastases
2002
Tumour Suppressor Genes in the Pathogenesis of Human Pituitary Tumours
1997
Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours
1999
Exploring the interactions between bacteriophage-encoded glycan binding proteins and carbohydrates
2015
Transfection of an Inducible p16/CDKN2A Construct Mediates Reversible Growth Inhibition and G1Arrest in the AtT20 Pituitary Tumor Cell Line
1999
Aberrant expression of G1/S regulators is a frequent event in sporadic pituitary adenomas
2001
Hypermethylation of thep16/CDKN2A/MTS1 gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas
1999
Development of an Assay for the Identification of Receptor Binding Proteins from Bacteriophages
2016
The Cyrenaican Prehistory Project 2009: the third season of investigations of the Haua Fteah cave and its landscape, and further results from the 2007–2008 fieldwork
2009
Site formation processes in caves: The Holocene sediments of the Haua Fteah, Cyrenaica, Libya
2010
Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins.
2000
Hypermethylation of the p16/CDKN2A/MTSI gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas.
1999
Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors.
1999
Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas.
1999
Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.
2000
Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.
1997
Molecular Pathology Shows p16 Methylation in Nonadenomatous Pituitaries from Patients with Cushing’s Disease
2004
Removal of enteric viruses and selected microbial indicators by UV irradiation of secondary effluent
2003